<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteTissue Engineering &#8211; Wyss Institute</title>
		<link>https://wyss.harvard.edu</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Tue, 26 May 2026 17:22:11 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.harvard.edu/discipline/tissue-engineering/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.7.1</generator>

		<!-- Start loop -->
		
			<item>
				<title>Decoding inflammatory bowel disease – on a chip</title>
				<link>https://wyss.harvard.edu/news/decoding-inflammatory-bowel-disease-on-a-chip/</link>
        <pubDate>Thu, 21 May 2026 09:30:43 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Gut-on-a-Chip]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Inflammation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45488</guid>
                            <description>Replication of patient- and sex-specific hallmarks of IBD in a human organ chip reveals stromal fibroblasts as drivers of inflammation, fibrosis, and enhanced cancer risk</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Inflammatory bowel disease (IBD), which comprises the inflammatory conditions Crohn&rsquo;s disease and ulcerative colitis, affects about 1.6 million Americans, many of whom cannot be effectively treated. This is mostly due to a lack of understanding of what exactly causes the increased inflammation, fibrosis, and compromised intestinal barrier that underlie this&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/decoding-inflammatory-bowel-disease-on-a-chip/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/decoding-inflammatory-bowel-disease-on-a-chip/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/05/20121105/Colon-Chip.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c60ba1aa68dd5c86bf69c58c19a8c841"/></url>
				</image>
        			</item>

		
			<item>
				<title>Multidisciplinary Wyss team receives 2026 Lush Prize Science Award</title>
				<link>https://wyss.harvard.edu/news/multidisciplinary-wyss-team-receives-2026-lush-prize-science-award/</link>
        <pubDate>Mon, 18 May 2026 18:30:48 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biosensors]]></category>
		<category><![CDATA[Boston Children's Hospital]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45467</guid>
                            <description>Recognition highlights the growing impact of Organ Chip technology in reducing animal testing in biomedical and women’s health research</description>
                                        <content:encoded><![CDATA[<p>(BOSTON) &mdash; The Wyss Institute for Biologically Inspired Engineering at Harvard University is proud to announce that the Biosensing, Microfluidics, and Microsystems team, led by Wyss Senior Engineer Adama Sesay, Ph.D., together with the Female Reproductive Health team, has received the 2026 Lush Science Prize. The prize recognizes their work developing next&#x2d;generation, sensor&#x2d;integrated human Organ&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/multidisciplinary-wyss-team-receives-2026-lush-prize-science-award/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/multidisciplinary-wyss-team-receives-2026-lush-prize-science-award/</link>
          <title>Wyss Research Scholar Zoheh Izadifar (left), a former Postdoctoral Fellow in the lab of Wyss Founding Director Donald Ingber, and now an Assistant Professor at Boston Children’s Hospital and Harvard Medical School, received the award on behalf of the Wyss teams during the Lush Prize award ceremony, held and livestreamed on May 12 in London. This photo shows her next to jury member Ellen Fritsche (right), Director of the Swiss Centre for Applied Human Toxicology (SCAHT) affiliated to the University of Basel. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/05/18113142/Zohreh-Izadifar-Science-LP26_Ellen-Fritsche-scaled-e1779118388548.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=a7846fa4b4163e138d93bb0cd4969b75"/></url>
				</image>
        			</item>

		
			<item>
				<title>Growing liver tissue on demand directly in the body</title>
				<link>https://wyss.harvard.edu/news/growing-liver-tissue-on-demand-directly-in-the-body/</link>
        <pubDate>Fri, 17 Apr 2026 17:55:10 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Gene Regulation]]></category>
		<category><![CDATA[MIT]]></category>
		<category><![CDATA[Organ Engineering]]></category>
		<category><![CDATA[Sangeeta Bhatia]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45268</guid>
                            <description>New study combines tissue engineering with synthetic biology tools to grow healthy liver tissue inside the body, and lays foundation for “smart” solid organ therapies</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; In patients developing end&#x2d;stage liver disease, the damage has become too severe for the liver&rsquo;s normally extraordinary regenerative capacity to repair or compensate for it. Once this &ldquo;point of no return&rdquo; has been reached, the only option is an organ transplant. However, getting a liver transplant is extremely difficult due to high demand and limited supply&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/growing-liver-tissue-on-demand-directly-in-the-body/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/growing-liver-tissue-on-demand-directly-in-the-body/</link>
          <title>Patients who develop end-stage liver disease have liver damage that has become too severe for the organ’s normally extraordinary regenerative capacity to repair or compensate for. From then on, their only option is an organ transplant. To help bridge the time until a donor organ becomes available, a Wyss-Boston University-MIT research team has innovated the “BOOST” strategy, which they demonstrated allows on-demand healthy liver growth of genetically engineered tissue constructs upon their implantation. Credit: Envato Elements/ drazenphoto</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/04/14170323/happy-senior-patient-talking-to-his-daughter-who-i-2026-03-16-03-27-50-utc-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=7d97cd936c84704ed7ffa9579f52afcf"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wyss Institute technologies enable breakthrough in astronaut health research aboard NASA’s Artemis II mission</title>
				<link>https://wyss.harvard.edu/news/wyss-institute-technologies-enable-breakthrough-in-astronaut-health-research-aboard-nasas-artemis-ii-mission/</link>
        <pubDate>Thu, 09 Apr 2026 14:55:20 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[BARDA]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Emulate Inc.]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[NASA]]></category>
		<category><![CDATA[Stem Cells]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45228</guid>
                            <description>Wyss Institute-enabled Organ Chip “avatars” will provide insights into astronaut health risks and provide a tool for future discovery of countermeasures necessary for travel to the Moon and beyond</description>
                                        <content:encoded><![CDATA[<p>By Alexandra Jirstrand (BOSTON) &ndash; Launched on April 1, 2026, Artemis II is a historic, approximately 10&#x2d;day lunar flyby mission that is sending four astronauts farther into space than any humans have traveled since the Apollo era, marking a critical step toward sustained lunar exploration and future missions to Mars. The Wyss Institute for Biologically Inspired Engineering at Harvard&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/wyss-institute-technologies-enable-breakthrough-in-astronaut-health-research-aboard-nasas-artemis-ii-mission/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/wyss-institute-technologies-enable-breakthrough-in-astronaut-health-research-aboard-nasas-artemis-ii-mission/</link>
          <title>Using Organ Chips containing astronaut cells, Wyss Institute and Emulate researchers will examine how radiation and microgravity impact human tissue. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/04/08174051/NASA-Bonemarrow-Chips-03480_Chip-on-Microscope-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=1f2bbd476766a3827d203d14fedb5a30"/></url>
				</image>
        			</item>

		
			<item>
				<title>20-ish Questions with Christopher Chen</title>
				<link>https://wyss.harvard.edu/media-post/20-ish-questions-with-christopher-chen/</link>
        <pubDate>Fri, 06 Feb 2026 14:00:53 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[3D printing]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[Christopher Chen]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=44763</guid>
                                                <content:encoded><![CDATA[<p>20&#x2d;ish Questions shows a different side of Wyss Institute faculty, touching on aspects of their personal life, hobbies, interests, as well as their research. This round follows Christopher Chen, M.D., Ph.D., a Core Faculty member at the Wyss Institute. He is also the William Fairfield Warren Distinguished Professor, Biomedical Engineering &amp; Director, Biological Design Center at Boston University.</p>
<p><a href="https://wyss.harvard.edu/media-post/20-ish-questions-with-christopher-chen/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/20-ish-questions-with-christopher-chen/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/02/03154255/THUMBNAIL_20-ish-Questions-with-Christopher-Chen_No-Text-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=01b52528b96068d1932c08da4f6aa41d"/></url>
				</image>
        			</item>

		
			<item>
				<title>Toward engineering a human kidney collecting duct system</title>
				<link>https://wyss.harvard.edu/news/toward-engineering-a-human-kidney-collecting-duct-system/</link>
        <pubDate>Fri, 30 Jan 2026 14:50:56 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Biological Materials]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Healthy Aging]]></category>
		<category><![CDATA[Implants]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
		<category><![CDATA[Organ Engineering]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44698</guid>
                            <description>Newly developed method to fabricate perfusable collecting ducts of the human kidney opens the door to disease modeling, drug testing, and organ engineering </description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; The human kidney filters about a cup of blood every minute, removing waste, excess fluid, and toxins from it, while also regulating blood pressure, balancing important electrolytes, activating Vitamin D, and helping the body produce red blood cells. This broad range of functions is achieved in part via the kidney&rsquo;s complex organization. In its outer region&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/toward-engineering-a-human-kidney-collecting-duct-system/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/toward-engineering-a-human-kidney-collecting-duct-system/</link>
          <title>As can be seen in this close-up, engineered UB tubules bud from the central channel and branch into the surrounding matrix. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/01/27145033/Budding-UB-tubules-copy.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=89285f076bfcbe6edbe7343007eba2bb"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wyss Institute-led collaboration awarded by ARPA-H PRINT program to engineer off-the-shelf, universal, transplant-ready graft for liver failure</title>
				<link>https://wyss.harvard.edu/news/wyss-institute-led-collaboration-awarded-by-arpa-h-print-program-to-engineer-off-the-shelf-universal-transplant-ready-graft-for-liver-failure/</link>
        <pubDate>Fri, 16 Jan 2026 14:55:47 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[ARPA-H]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[Implants]]></category>
		<category><![CDATA[MIT]]></category>
		<category><![CDATA[Organ Engineering]]></category>
		<category><![CDATA[Sangeeta Bhatia]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44566</guid>
                            <description>Highly multidisciplinary, multi-institutional team of world-leading experts to build technological foundation for liver transplants that could save thousands of patients</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; The majority of human illnesses are caused by damage to a single organ, like the liver, whose failure accounts for 2M deaths worldwide every year. Orthotopic transplants are the only curative therapy available, but the severe shortage of donor organs, which are reserved for the most severe cases, leaves millions of patients without an accessible solution.</p>
<p><a href="https://wyss.harvard.edu/news/wyss-institute-led-collaboration-awarded-by-arpa-h-print-program-to-engineer-off-the-shelf-universal-transplant-ready-graft-for-liver-failure/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/wyss-institute-led-collaboration-awarded-by-arpa-h-print-program-to-engineer-off-the-shelf-universal-transplant-ready-graft-for-liver-failure/</link>
          <title>To address liver failure in many of over 500M patients worldwide, the highly collaborative ImPLANT project funded by the ARPA-H Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) program, world-leading researchers from the Wyss Institute at Harvard University, MIT, University of Colorado Boulder, and Columbia University join their expertise to create the multidisciplinary technological framework for building the first off-the-shelf engineered graft. Credit: Gerain0812/Envato</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/01/13141545/Team-of-surgeons-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=40a3e07721c1778ee52413e6e5c8b98c"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wyss Institute Core Faculty member Christopher S. Chen elected to the National Academy of Medicine</title>
				<link>https://wyss.harvard.edu/news/wyss-institute-core-faculty-member-christopher-s-chen-elected-to-the-national-academy-of-medicine/</link>
        <pubDate>Tue, 21 Oct 2025 13:28:06 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[National Academy of Medicine]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44010</guid>
                            <description>Chen has been recognized “for pioneering contributions and leadership in cell and tissue engineering, particularly in the micro-nano-bio engineering of cell and tissue assembly, structure, mechanics, and function"</description>
                                        <content:encoded><![CDATA[<p>By Alexandra Jirstrand (BOSTON) &mdash; Christopher S. Chen, M.D., Ph.D., Core Faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University, and the William F. Warren Distinguished Professor of Biomedical Engineering at Boston University, has been elected to the National Academy of Medicine (NAM), one of the highest honors in the fields of health and medicine.</p>
<p><a href="https://wyss.harvard.edu/news/wyss-institute-core-faculty-member-christopher-s-chen-elected-to-the-national-academy-of-medicine/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/wyss-institute-core-faculty-member-christopher-s-chen-elected-to-the-national-academy-of-medicine/</link>
          <title>Christopher Chen. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2016/08/05093200/Christopher_Chen_headshot_1500x1000.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c9d41927da733dab74c8a834f1cd038b"/></url>
				</image>
        			</item>

		
			<item>
				<title>Human Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies</title>
				<link>https://wyss.harvard.edu/news/human-organ-chip-technology-sets-stage-for-pan-influenza-a-crispr-rna-therapies/</link>
        <pubDate>Wed, 15 Oct 2025 13:55:54 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biomimetic Microsystems]]></category>
		<category><![CDATA[CRISPR]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[Lung-on-a-chip]]></category>
		<category><![CDATA[Nanoparticles]]></category>
		<category><![CDATA[Natalie Artzi]]></category>
		<category><![CDATA[Pathogen]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43920</guid>
                            <description>Human lung alveolus chip infection model enables investigation of viral replication, inflammatory responses, and genetic off-target effects of a novel pan-influenza CRISPR therapy</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &ndash; The Influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally. In the U.S. alone, it is estimated that, despite seasonally updated vaccines, IAV infections still lead to 140,000 to 710,000 hospitalizations and 12,000 to 52,000 deaths annually. The development of antiviral treatments against IAV&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/human-organ-chip-technology-sets-stage-for-pan-influenza-a-crispr-rna-therapies/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/human-organ-chip-technology-sets-stage-for-pan-influenza-a-crispr-rna-therapies/</link>
          <title>New findings show that future pan-influenza A vaccines based on CRISPR technology can be preclinically assessed in human Organ Chips. Credit: Envato Elements/dvatri</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/10/14105510/portrait-of-a-family-activities-at-home-2025-09-14-16-44-58-utc-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c1f3463c4436feb34fe1078d4163cfb9"/></url>
				</image>
        			</item>

		
			<item>
				<title>Precision oncology Organ Chip platform accurately and actionably predicts chemotherapy responses of patients suffering from esophageal adenocarcinoma</title>
				<link>https://wyss.harvard.edu/news/precision-oncology-organ-chip-platform-accurately-and-actionably-predicts-chemotherapy-responses-of-patients-suffering-from-esophageal-adenocarcinoma/</link>
        <pubDate>Fri, 27 Jun 2025 13:20:57 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biomimetic Microsystems]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Extracellular Matrix]]></category>
		<category><![CDATA[Stem Cells]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43161</guid>
                            <description>Patient-matched Organ Chips mimicking the tumor microenvironment can effectively personalize chemotherapy selection in cancer patients </description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for which no effective targeted therapy exists. Patients need to rely on chemotherapy as a standard&#x2d;of&#x2d;care, which is started ahead of surgical interventions as a so&#x2d;called &ldquo;neoadjuvant chemotherapy&rdquo; (NACT) in the hope to shrink or control tumors.</p>
<p><a href="https://wyss.harvard.edu/news/precision-oncology-organ-chip-platform-accurately-and-actionably-predicts-chemotherapy-responses-of-patients-suffering-from-esophageal-adenocarcinoma/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/precision-oncology-organ-chip-platform-accurately-and-actionably-predicts-chemotherapy-responses-of-patients-suffering-from-esophageal-adenocarcinoma/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/06/24154351/Figure-5_Listing-Image.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=e703f00b8f5e398227f8eaad82a40a7f"/></url>
				</image>
        			</item>

			</channel>
</rss>
